Bioxytran completes $1.2M private placement, issues 21.1M shares and 19.8M warrants

BIOXYTRAN, INC

Gross proceeds of approximately $1.2 million from sale of 21,071,667 shares at $0.055 per share.
Warrants issued to purchase up to 19,750,001 shares at $0.12 per share, exercisable immediately for five years.
Net proceeds to fund working capital, development programs, and commercialization of A-SUQAR dietary supplement.
Transaction closed March 18, 2026; securities sold to accredited investors under Regulation D exemption.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.